Compare CHD & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHD | BNTX |
|---|---|---|
| Founded | 1846 | 2008 |
| Country | United States | Germany |
| Employees | 5550 | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.4B | 22.8B |
| IPO Year | 2014 | 2019 |
| Metric | CHD | BNTX |
|---|---|---|
| Price | $94.00 | $86.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 13 |
| Target Price | $102.06 | ★ $134.15 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 04-30-2026 | 03-10-2026 |
| Dividend Yield | ★ 1.30% | N/A |
| EPS Growth | ★ 27.43 | N/A |
| EPS | ★ 3.02 | N/A |
| Revenue | ★ $6,203,200,000.00 | N/A |
| Revenue This Year | $0.01 | N/A |
| Revenue Next Year | $3.68 | $4.76 |
| P/E Ratio | $31.40 | ★ N/A |
| Revenue Growth | ★ 1.57 | N/A |
| 52 Week Low | $81.33 | $79.81 |
| 52 Week High | $113.91 | $124.00 |
| Indicator | CHD | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 33.71 | 34.03 |
| Support Level | $91.10 | $79.81 |
| Resistance Level | $96.26 | $113.12 |
| Average True Range (ATR) | 1.85 | 3.04 |
| MACD | -1.01 | -0.65 |
| Stochastic Oscillator | 5.08 | 29.83 |
Church & Dwight is the leading global producer of baking soda. Its portfolio extends beyond its legacy category to include laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its brands also include Batiste, OxiClean, Vitafusion, Hero, and TheraBreath, which, together with Arm & Hammer, account for around 70% of its annual sales and profits. Most recently, the firm added Touchland and its hand sanitizer business to its fold. Even as it works to expand its product reach, Church & Dwight still derives around 80% of its sales from its home market in the US.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.